Header Social Media

Main navigation

Our Research
Researchers and Clinicians
Patient and Families
Early Stage Investigators
News and Events
About Us
Podcast
- PIDTC Podcast

A Previously-Funded NIH Rare Diseases Clinical Research Network Consortium

Call for Abstracts for the PIDTC Scientific Workshop

Dear PIDTC Investigators and study teams,

Applications for the Annual Primary Immune Deficiency Treatment Consortium (PIDTC) Education Day are now open for the 2027 meeting which will take place March 9^th and 10^th, followed by the Annual Scientific Workshop.

Submission is due by 5pm Pacific time December 7th, 2026 to Lisa Lim at Lisa.Lim@ucsf.edu. Notification of acceptance and mentor assignments will be sent in early January 2026.

*Please note this Program is different from the Abstract Submission Process for Scientific Meeting attendees.

Thank you,

Lisa (On behalf of Drs. Heimall, Arnold and Oved and the 2027 Education Day Planning Committee)

2027 Abstract Submission Form

Footer menu

Web Policies
Genetic and Rare Diseases Information Center
Members Login
Contact Us

The Primary Immune Deficiency Treatment Consortium (PIDTC) is a previously funded research group of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). PIDTC received funding under grant number U54AI082973 as a collaboration between NCATS and the National Institute of Allergy and Infectious Diseases (NIAID). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke NINDS) under grant number TR002818. The content of this website is solely the responsibility of the PIDTC administrative coordinating center at University of California, San Francisco and does not necessarily represent the official views of the NIH.